Thornburg Investment Management Inc Gilead Sciences, Inc. Transaction History

Thornburg Investment Management Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $38.7 Million - $44.9 Million	-534,689 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $18.1 Million - $23.1 Million	-288,449 Reduced 35.04%	534,689 $40 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $26.5 Million - $29.1 Million	-429,993 Reduced 34.31%	823,138 $53.5 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $1.04 Million - $1.15 Million	16,674 Added 1.35%	1,253,131 $79.4 Million
Q2 2019 Aug 06, 2019	SELL	$61.87 - $69.38 $2.43 Million - $2.73 Million	-39,316 Reduced 3.08%	1,236,457 $83.5 Million
Q1 2019 May 07, 2019	BUY	$62.53 - $70.05 $9 Million - $10.1 Million	143,916 Added 12.72%	1,275,773 $82.9 Million
Q4 2018 Feb 06, 2019	SELL	$60.54 - $79.0 $4.34 Million - $5.66 Million	-71,629 Reduced 5.95%	1,131,857 $70.8 Million
Q3 2018 Nov 02, 2018	BUY	$71.28 - $78.92 $346,777 - $383,945	4,865 Added 0.41%	1,203,486 $92.9 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $1.7 Million - $1.98 Million	26,151 Added 2.23%	1,198,621 $84.9 Million
Q1 2018 May 07, 2018	SELL	$72.84 - $88.8 $5.17 Million - $6.31 Million	-71,015 Reduced 5.71%	1,172,470 $88.4 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $521,173 - $611,784	7,325 Added 0.59%	1,243,485 $89.1 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $83,575 - $99,059	1,159 Added 0.09%	1,236,160 $100 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,235,001	1,235,001 $87.4 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Thornburg Investment Management Inc with notifications on news.